Raleigh, NC, United States of America

Jonathan Bryan DeCamp

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
6 patents (USPTO):

Title: Innovations of Jonathan Bryan DeCamp

Introduction

Jonathan Bryan DeCamp is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cytoskeletal reorganization. With a total of 6 patents to his name, DeCamp's work has the potential to impact various medical conditions.

Latest Patents

One of his latest patents is focused on cytoskeletal active rho kinase inhibitor compounds, which are designed to inhibit rho-associated protein kinase. This invention includes pharmaceutical compositions that comprise these compounds along with a pharmaceutically acceptable carrier. The patent also outlines methods for preventing or treating diseases associated with cytoskeletal reorganization, such as primary open-angle glaucoma. The method involves administering a therapeutically effective amount of a cytoskeletal active compound, which influences actomyosin interactions, leading to cellular relaxation and changes in cell-substratum adhesions.

Career Highlights

DeCamp is currently associated with Inspire Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for conditions that affect the cytoskeleton.

Collaborations

Throughout his career, DeCamp has collaborated with notable colleagues, including Paul Steven Watson and David J Slade. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jonathan Bryan DeCamp is a distinguished inventor whose work in cytoskeletal active compounds holds promise for treating significant medical conditions. His contributions to the field are marked by innovation and collaboration, making him a key figure in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…